IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 228 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,673 | -20.6% | 1,026,965 | +22.9% | 0.01% | -12.5% |
| Q2 2023 | $5,882 | +42.1% | 835,494 | +23.4% | 0.01% | +33.3% |
| Q1 2023 | $4,138 | +9.5% | 677,309 | +14.5% | 0.01% | +20.0% |
| Q4 2022 | $3,780 | -99.9% | 591,523 | +4.8% | 0.01% | -37.5% |
| Q3 2022 | $5,408,000 | -11.7% | 564,495 | +1.7% | 0.01% | 0.0% |
| Q2 2022 | $6,125,000 | -29.5% | 554,825 | +6.4% | 0.01% | -11.1% |
| Q1 2022 | $8,686,000 | -12.8% | 521,689 | 0.0% | 0.01% | -10.0% |
| Q4 2021 | $9,959,000 | -36.1% | 521,689 | -17.4% | 0.01% | -41.2% |
| Q3 2021 | $15,574,000 | -8.4% | 631,553 | -3.3% | 0.02% | -5.6% |
| Q2 2021 | $16,997,000 | -16.4% | 653,231 | +1.7% | 0.02% | -18.2% |
| Q1 2021 | $20,327,000 | -35.6% | 642,032 | -5.6% | 0.02% | -37.1% |
| Q4 2020 | $31,559,000 | +37.2% | 680,151 | -2.6% | 0.04% | +25.0% |
| Q3 2020 | $22,995,000 | +20.9% | 698,510 | +0.8% | 0.03% | +16.7% |
| Q2 2020 | $19,017,000 | +40.8% | 692,794 | +53.6% | 0.02% | +20.0% |
| Q1 2020 | $13,505,000 | +16.8% | 451,141 | +8.0% | 0.02% | +42.9% |
| Q4 2019 | $11,563,000 | +78.9% | 417,739 | +17.6% | 0.01% | +75.0% |
| Q3 2019 | $6,464,000 | -19.5% | 355,138 | +8.5% | 0.01% | -20.0% |
| Q2 2019 | $8,027,000 | +785.0% | 327,368 | +243.2% | 0.01% | +900.0% |
| Q1 2019 | $907,000 | +27.2% | 95,400 | +18.4% | 0.00% | 0.0% |
| Q4 2018 | $713,000 | -30.6% | 80,600 | -11.8% | 0.00% | 0.0% |
| Q3 2018 | $1,028,000 | -12.1% | 91,400 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $1,170,000 | -11.9% | 91,400 | +16.3% | 0.00% | -50.0% |
| Q1 2018 | $1,328,000 | +225.5% | 78,600 | +54.1% | 0.00% | – |
| Q4 2017 | $408,000 | +3.3% | 51,000 | 0.0% | 0.00% | -100.0% |
| Q3 2017 | $395,000 | +5.3% | 51,000 | 0.0% | 0.00% | – |
| Q2 2017 | $375,000 | – | 51,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 11,826,299 | $130,562,000 | 4.09% |
| MPM BioImpact LLC | 1,200,000 | $13,248,000 | 3.68% |
| Finepoint Capital LP | 960,200 | $10,601,000 | 3.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,011 | $273,000,000 | 2.85% |
| Avoro Capital Advisors LLC | 9,220,000 | $101,789,000 | 2.01% |
| Long Focus Capital Management, LLC | 1,625,000 | $17,940,000 | 1.88% |
| 683 Capital Management, LLC | 2,000,000 | $22,080,000 | 1.56% |
| Parametrica Management Ltd | 115,870 | $1,268,000 | 1.38% |
| Boxer Capital, LLC | 1,935,133 | $21,364,000 | 1.35% |
| Soleus Capital Management, L.P. | 719,600 | $7,944,000 | 1.24% |